Yale Bulletin and Calendar

March 31, 2006|Volume 34, Number 24


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Cholesterol-lowering drugs shown
to reduce mortality during stroke

Patients given lipid-lowering agents (LLAs) during an ischemic stroke have a considerably higher survival rate than patients who do not use the cholesterol-reducing drugs, according to recent research by School of Medicine investigators.

Led by Norrina B. Allen, a graduate student in the Department of Epidemiology and Public Health (EPH), the study was presented recently at the American Stroke Association's International Stroke Conference.

The research showed that those given LLAs, primarily of the statin class, within 48 hours of their stroke had a 1% mortality rate in the hospital, compared to the 5.3% rate for patients who were not given this treatment. Statins are drugs that inhibit cholesterol production in the liver.

Allen and her co-authors reviewed the University Health System Consortium Ischemic Stroke Benchmarking Project, which included data from the hospital charts of 1,256 stroke patients who were treated from January to June 2004 at 32 academic hospitals. They studied deaths in the hospital occurring over 48 hours after hospital admission and also examined the outcomes for patients who were discharged from the hospital.

"This study suggests an interesting association between LLAs and mortality that needs to be investigated further," says Allen. "These findings may provide insights into potential opportunities for acute stroke treatment."

Ischemic strokes account for over 80% of all strokes and occur when blood vessels to the brain become narrowed or clogged, cutting off blood flow to brain cells.

Allen says further studies are needed to fully understand the relationship between the use of statins during acute ischemic stroke and in-hospital mortality.

Other researchers included the late Dr. Lawrence M. Brass, Julie Cerese, Jackie Dostal, Joanne Cuny and Judith H. Lichtman.

-- By Karen Peart


T H I SW E E K ' SS T O R I E S

Study: Too much or too little sleep raises diabetes risk

Juniors to continue science studies as Goldwater Scholar

Scientists learn being a 'lefty' aids survival -- if you're a snail

International journalists describe their fight for justice

Getting a little snippy

Steven Smith to serve a third term as Branford College master

HHMI funds new program to train students involved in . . .

New OCR programs allow for the scientific sharing . . .

Library acquires archive of photographer Robert Giard

Events to explore legacy of Hiroshima, nuclear proliferation

Impact of political leadership to be examined in conference

Yale Opera productions span the globe and the centuries

Not planning too far ahead is one of the keys to career success . . .

MEDICAL SCHOOL NEWS

Scientist Andreas Wallraff is lauded for work in quantum device research

Yale teams to take part in fight against cancer through relay

A salute to service

Student 'inventors' will participate in 'Leonardo Challenge'

First-rate science

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home